期刊文献+

孕中期血清产前筛查与不良妊娠结局的相关性分析 被引量:10

原文传递
导出
摘要 目的了解孕中期血清产前筛查结果与胎儿结构畸形、死胎、流产等不良妊娠结局的相关性,为临床预测和干预某些不良妊娠结局的发生提供依据。方法对宁波市2004年1月至2010年9月有孕中期血清产前筛查,并结束妊娠的妇女,按不同风险组作出生缺陷、流产、死胎发生率的统计,并进行x2检验,以P〈0.05为差异有统计学意义。结果7年间宁波市进行孕中期血清产前筛查并结束妊娠的妇女247363例发现出生缺陷3651例(14.76‰),其中筛查高风险孕妇8555例,占筛查数的3.46%。高风险人群中发现胎儿出生缺陷873例,其出生缺陷发生率为102.05‰,238808例低风险的孕妇中发现胎儿出生缺陷2778例,其出生缺陷发生率为11.63‰(x2=4642.74,P〈0.01)。高风险孕妇中发现除21三体、18三体和神经管畸形外的胎儿其他畸形704例,发生率为82.29‰(704/8555),低风险孕妇中发现其他畸形2732例,发生率为1i.44‰(2732/238808)(x2=3026.78,P〈0.01)。高风险孕妇发生死胎222例,发生率为2.59%(222/8555),低风险孕妇发生死胎591例,死胎发生率为0.25%(591/238808)(x2=1389.37,P〈0.01)。2008年至2010年的自然流产发生率分别为高风险孕妇4.58%(159/3470),低风险孕妇0.12%(148/125664),(x2=2837.62,P〈0.01)。结论血清产前筛查高风险人群中除了预期的21三体、18三体和神经管畸形外,其他的出生缺陷明显增加,死胎和流产的发生率也高,应加强这一人群的监测和保健指导。
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2012年第5期608-610,共3页 Chinese Journal of Medical Genetics
基金 宁波市社会发展项目(2011C50067)
  • 相关文献

参考文献7

  • 1Merkatz IR, Nitowsky HM, Macri JN, et al. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol, 1984, 148: 886-894.
  • 2焦红燕,章小维,时春艳.孕中期血清标志物在产前筛查和妊娠结局预测中的意义[J].中国优生与遗传杂志,2006,14(12):62-64. 被引量:13
  • 3商敏,马彦彦.唐氏综合征血清筛查[J].中华围产医学杂志,2003,6(3):190-192. 被引量:69
  • 4Farrant W. Stress after amniocentesis for high serum alpha-fetoprotein concentrations. BMJ, 2001, 281:452.
  • 5Palacio M, Jauniaux E, Kingdom J, et at. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free β-human chorionic gonadotropin. Ultrasound Obstet Gynecol, 1999,13:58-62.
  • 6刘志婷,王军荣,续微,关宝杰.染色体多态性引起生殖异常36例分析[J].中华医学遗传学杂志,2006,23(5):598-599. 被引量:57
  • 7段涛,胡娅莉,吕时铭,主译.产前诊断.第1版.北京:人民卫生出版社,2010.5.

二级参考文献11

  • 1Stojilkovic-Mikic T,Rodeck CH.Antenatal screening policies for Down′s syndrome[J].BMJ,2002,1034(2):325.
  • 2Michael T,Mennuti M D,Deborah A,et al.Screening for Down′s syndrome-too many choices?[J].New England Journal of Medicine,2003,349:1471-1473.
  • 3Merkatz IR,Nitowsky HM,Macri JN,et al.An association between low maternal serum alpha-fetoprotein and fetal chromosomaI abnormalities[J].Am J Obstet Gynecol,1984 Aprl,48(7):886-894.
  • 4Goetzl L,Krantz D,Simpson JL,Silver RK,et al.Pregnancy-addociated plasma protein A,free beta-hcg,nuchal translucency,and risk ofpregnancy loss[J].Obstet Gynecol,2004 Jun,104(1):30-6.
  • 5Akinbiyi M.Unexplained elevated maternal serum alpha-fetoprotein in singletion pregnancies as a prediction offetal risk[J].J Gynecol Obstet,1996,53:17-21.
  • 6Yao YG,Duh EJ.VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cell:a mechanism for feedback regulation of angiogenesis[J]?.Biochem Biophys Res Commun,2004,32 1(3):648-656.
  • 7American College of Obstetricians and Gynecologists.Prenatal diagnosis of fetal chromosomal abnomalities[M].ACOG Practice Bulletin 27.Washington,DC:ACOG:2001.
  • 8American College of Medical Genetics.ACMG position statement on multiple marker screening in womeen 35 and older,1994.Available at:ttp://www.Acing.net/resources/policies/pol-022[J]Asp.Retrieved October 6,2003.
  • 9Wald NJ,Watt HC.Serum markers for Down′s syndrome in relation to number of previous births and maternal age[J].Prenat Diagn,1996,16:699-703.
  • 10Eloranta ML,Heinonen S,Kirkinen P.Intrahepatic cholestasis ofpregnancy has no effect on maternal serum second trimester alpha-retoprotein and HCG[J].Aeta Obstet Gynecol Scand,2000,79(71):548-552.

共引文献134

同被引文献75

  • 1王林林,何怡华,李治安.胎儿先天性心脏病的病因学研究进展[J].中华医学超声杂志(电子版),2011,8(9):2017-2023. 被引量:9
  • 2谭梅娟,黄民主,李登清,易著文,黄日茂4.孕早期环境因素与儿童先天性心脏病关系的病例-对照研究[J].环境与健康杂志,2006,23(5):427-430. 被引量:29
  • 3焦红燕,章小维,时春艳.孕中期血清标志物在产前筛查和妊娠结局预测中的意义[J].中国优生与遗传杂志,2006,14(12):62-64. 被引量:13
  • 4EvansMI,JohnsonMP,YaronY.产前诊断[M].段涛,胡娅莉,吕时铭,译.北京:人民卫生出版社,2010:144-152.
  • 5谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 6DUGOFF L. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes [J]. Obstet Gynecol, 2010, 115(5):1052-1061.
  • 7D'ANTONIO F, RIJO C, THILAGANATHAN B, et al. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications[J]. Prenat Diagn, 2013,33(9):839-847.
  • 8LAURA J P, REBECCA B, ROBERT C, et al. Association between eclampsia, maternal characteristics, and abnormal levels of first and second trimester serum biomarkers[J]. Reprod Sci, 2014,21(3):297A.
  • 9ODIBO A, ZHONG Y, KATHERINE R, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia[J]. Placenta, 2011,32(8):598-602.
  • 10UCCELLA S, COLOMBO G F, BULGHERONI C M, et al. First-trimester maternal serum screening and the risk for fetal distress during labor [J]. Am J Obstet Gynecol, 2009,201(2):166.e1-6.

引证文献10

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部